Treatment of Uterine Myoma with 2.5 or 5 mg Mifepristone Daily during 3 Months with 9 Months Posttreatment Followup: Randomized Clinical Trial

Table 2

Changes in fibroid volumes (c.c.) by treatment groups and evaluation periods.

Evaluation at	Group	𝑛	Mean ± S.D.	95% CI for mean	Changes (%)	𝑃^∗
Before treatment	2.5 mg	110	136 ± 129	105–162	—	.151
	5 mg	110	112 ± 118	72–115
3-month treatment	2.5 mg	102	98 ± 107	76–119	27.9 ↓	.003
	5 mg	106	60 ± 67	47–74	46.4 ↓
3-month followup	2.5 mg	98	115 ± 144	85–153	15.4 ↓	.052
	5 mg	104	80 ± 109	51–84	28.6 ↓
6-month followup	2.5 mg	93	112 ± 141	88–154	17.6 ↓	.086
	5 mg	103	81 ± 110	48–88	27.7 ↓
9-month followup	2.5 mg	90	129 ± 157	97–167	5.1 ↓	.105
	5 mg	100	99 ± 91	69–118	11.6 ↓

^∗𝑡-test (ANOVA); CI: confidence interval; SD: standard deviation.